Antiretroviral therapy promotes significant increases of IL-2+IFN-γ+- and IL-2+TNF-α+- secreting CD4+ T cells and hinders the progression from infection to active TB, while single IFN-γ+ CD4+ T cells declined significantly [55]. Here, IFNG is linked to infection.